Pereira LM, Langley PG, Hayllar KM, Tredger JM, Williams R (1992)
In some instances, intratympanic injections require the need of a specialist and the formulation or composition needs to be delivered to a specific site of the ear to maximize efficiency of the medication delivered
Tepezza, Tezspire growing Key Peptide Products: MariTide (maridebart cafraglutide GLP-1R agonist/GIPR antagonist peptide-antibody conjugate, Phase 2/3 pipeline for obesity), Nplate (romiplostim Fc-peptide fusion for ITP), Tezspire (tezepelumab, with AstraZeneca), Aimovig (erenumab CGRP receptor mAb for migraine) Therapeutic Segments: General Medicine (Repatha, Aimovig, Otezla)
Existing research is often hampered by small sample sizes, inadequate control groups (making comparisons difficult), and lack of publication in reputable journals